Global Oral Anti-diabetes Drugs Market Insights, Forecast to 2028

Report ID: 1754099 | Published Date: Jan 2025 | No. of Page: 119 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Oral Anti-diabetes Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Liquid
        1.2.3 Capsule
        1.2.4 Tablet
    1.3 Market by Application
        1.3.1 Global Oral Anti-diabetes Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Oral Anti-diabetes Drugs Market Perspective (2017-2028)
    2.2 Oral Anti-diabetes Drugs Growth Trends by Region
        2.2.1 Oral Anti-diabetes Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Oral Anti-diabetes Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Oral Anti-diabetes Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Oral Anti-diabetes Drugs Market Dynamics
        2.3.1 Oral Anti-diabetes Drugs Industry Trends
        2.3.2 Oral Anti-diabetes Drugs Market Drivers
        2.3.3 Oral Anti-diabetes Drugs Market Challenges
        2.3.4 Oral Anti-diabetes Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Oral Anti-diabetes Drugs Players by Revenue
        3.1.1 Global Top Oral Anti-diabetes Drugs Players by Revenue (2017-2022)
        3.1.2 Global Oral Anti-diabetes Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Oral Anti-diabetes Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Oral Anti-diabetes Drugs Revenue
    3.4 Global Oral Anti-diabetes Drugs Market Concentration Ratio
        3.4.1 Global Oral Anti-diabetes Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Oral Anti-diabetes Drugs Revenue in 2021
    3.5 Oral Anti-diabetes Drugs Key Players Head office and Area Served
    3.6 Key Players Oral Anti-diabetes Drugs Product Solution and Service
    3.7 Date of Enter into Oral Anti-diabetes Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Anti-diabetes Drugs Breakdown Data by Type
    4.1 Global Oral Anti-diabetes Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Oral Anti-diabetes Drugs Forecasted Market Size by Type (2023-2028)
5 Oral Anti-diabetes Drugs Breakdown Data by Application
    5.1 Global Oral Anti-diabetes Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Oral Anti-diabetes Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Oral Anti-diabetes Drugs Market Size (2017-2028)
    6.2 North America Oral Anti-diabetes Drugs Market Size by Type
        6.2.1 North America Oral Anti-diabetes Drugs Market Size by Type (2017-2022)
        6.2.2 North America Oral Anti-diabetes Drugs Market Size by Type (2023-2028)
        6.2.3 North America Oral Anti-diabetes Drugs Market Share by Type (2017-2028)
    6.3 North America Oral Anti-diabetes Drugs Market Size by Application
        6.3.1 North America Oral Anti-diabetes Drugs Market Size by Application (2017-2022)
        6.3.2 North America Oral Anti-diabetes Drugs Market Size by Application (2023-2028)
        6.3.3 North America Oral Anti-diabetes Drugs Market Share by Application (2017-2028)
    6.4 North America Oral Anti-diabetes Drugs Market Size by Country
        6.4.1 North America Oral Anti-diabetes Drugs Market Size by Country (2017-2022)
        6.4.2 North America Oral Anti-diabetes Drugs Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Oral Anti-diabetes Drugs Market Size (2017-2028)
    7.2 Europe Oral Anti-diabetes Drugs Market Size by Type
        7.2.1 Europe Oral Anti-diabetes Drugs Market Size by Type (2017-2022)
        7.2.2 Europe Oral Anti-diabetes Drugs Market Size by Type (2023-2028)
        7.2.3 Europe Oral Anti-diabetes Drugs Market Share by Type (2017-2028)
    7.3 Europe Oral Anti-diabetes Drugs Market Size by Application
        7.3.1 Europe Oral Anti-diabetes Drugs Market Size by Application (2017-2022)
        7.3.2 Europe Oral Anti-diabetes Drugs Market Size by Application (2023-2028)
        7.3.3 Europe Oral Anti-diabetes Drugs Market Share by Application (2017-2028)
    7.4 Europe Oral Anti-diabetes Drugs Market Size by Country
        7.4.1 Europe Oral Anti-diabetes Drugs Market Size by Country (2017-2022)
        7.4.2 Europe Oral Anti-diabetes Drugs Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Oral Anti-diabetes Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Oral Anti-diabetes Drugs Market Size by Type
        8.2.1 Asia-Pacific Oral Anti-diabetes Drugs Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Oral Anti-diabetes Drugs Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Oral Anti-diabetes Drugs Market Share by Type (2017-2028)
    8.3 Asia-Pacific Oral Anti-diabetes Drugs Market Size by Application
        8.3.1 Asia-Pacific Oral Anti-diabetes Drugs Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Oral Anti-diabetes Drugs Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Oral Anti-diabetes Drugs Market Share by Application (2017-2028)
    8.4 Asia-Pacific Oral Anti-diabetes Drugs Market Size by Region
        8.4.1 Asia-Pacific Oral Anti-diabetes Drugs Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Oral Anti-diabetes Drugs Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Oral Anti-diabetes Drugs Market Size (2017-2028)
    9.2 Latin America Oral Anti-diabetes Drugs Market Size by Type
        9.2.1 Latin America Oral Anti-diabetes Drugs Market Size by Type (2017-2022)
        9.2.2 Latin America Oral Anti-diabetes Drugs Market Size by Type (2023-2028)
        9.2.3 Latin America Oral Anti-diabetes Drugs Market Share by Type (2017-2028)
    9.3 Latin America Oral Anti-diabetes Drugs Market Size by Application
        9.3.1 Latin America Oral Anti-diabetes Drugs Market Size by Application (2017-2022)
        9.3.2 Latin America Oral Anti-diabetes Drugs Market Size by Application (2023-2028)
        9.3.3 Latin America Oral Anti-diabetes Drugs Market Share by Application (2017-2028)
    9.4 Latin America Oral Anti-diabetes Drugs Market Size by Country
        9.4.1 Latin America Oral Anti-diabetes Drugs Market Size by Country (2017-2022)
        9.4.2 Latin America Oral Anti-diabetes Drugs Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Oral Anti-diabetes Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Oral Anti-diabetes Drugs Market Size by Type
        10.2.1 Middle East & Africa Oral Anti-diabetes Drugs Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Oral Anti-diabetes Drugs Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Oral Anti-diabetes Drugs Market Share by Type (2017-2028)
    10.3 Middle East & Africa Oral Anti-diabetes Drugs Market Size by Application
        10.3.1 Middle East & Africa Oral Anti-diabetes Drugs Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Oral Anti-diabetes Drugs Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Oral Anti-diabetes Drugs Market Share by Application (2017-2028)
    10.4 Middle East & Africa Oral Anti-diabetes Drugs Market Size by Country
        10.4.1 Middle East & Africa Oral Anti-diabetes Drugs Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Oral Anti-diabetes Drugs Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Sanofi
        11.1.1 Sanofi Company Details
        11.1.2 Sanofi Business Overview
        11.1.3 Sanofi Oral Anti-diabetes Drugs Introduction
        11.1.4 Sanofi Revenue in Oral Anti-diabetes Drugs Business (2017-2022)
        11.1.5 Sanofi Recent Developments
    11.2 Eli Lilly
        11.2.1 Eli Lilly Company Details
        11.2.2 Eli Lilly Business Overview
        11.2.3 Eli Lilly Oral Anti-diabetes Drugs Introduction
        11.2.4 Eli Lilly Revenue in Oral Anti-diabetes Drugs Business (2017-2022)
        11.2.5 Eli Lilly Recent Developments
    11.3 AstraZeneca plc
        11.3.1 AstraZeneca plc Company Details
        11.3.2 AstraZeneca plc Business Overview
        11.3.3 AstraZeneca plc Oral Anti-diabetes Drugs Introduction
        11.3.4 AstraZeneca plc Revenue in Oral Anti-diabetes Drugs Business (2017-2022)
        11.3.5 AstraZeneca plc Recent Developments
    11.4 Astellas Pharma Inc
        11.4.1 Astellas Pharma Inc Company Details
        11.4.2 Astellas Pharma Inc Business Overview
        11.4.3 Astellas Pharma Inc Oral Anti-diabetes Drugs Introduction
        11.4.4 Astellas Pharma Inc Revenue in Oral Anti-diabetes Drugs Business (2017-2022)
        11.4.5 Astellas Pharma Inc Recent Developments
    11.5 Johnson & Johnson (Janssen Pharmaceuticals)
        11.5.1 Johnson & Johnson (Janssen Pharmaceuticals) Company Details
        11.5.2 Johnson & Johnson (Janssen Pharmaceuticals) Business Overview
        11.5.3 Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Introduction
        11.5.4 Johnson & Johnson (Janssen Pharmaceuticals) Revenue in Oral Anti-diabetes Drugs Business (2017-2022)
        11.5.5 Johnson & Johnson (Janssen Pharmaceuticals) Recent Developments
    11.6 Boehringer Ingelheim
        11.6.1 Boehringer Ingelheim Company Details
        11.6.2 Boehringer Ingelheim Business Overview
        11.6.3 Boehringer Ingelheim Oral Anti-diabetes Drugs Introduction
        11.6.4 Boehringer Ingelheim Revenue in Oral Anti-diabetes Drugs Business (2017-2022)
        11.6.5 Boehringer Ingelheim Recent Developments
    11.7 Merck
        11.7.1 Merck Company Details
        11.7.2 Merck Business Overview
        11.7.3 Merck Oral Anti-diabetes Drugs Introduction
        11.7.4 Merck Revenue in Oral Anti-diabetes Drugs Business (2017-2022)
        11.7.5 Merck Recent Developments
    11.8 Takeda
        11.8.1 Takeda Company Details
        11.8.2 Takeda Business Overview
        11.8.3 Takeda Oral Anti-diabetes Drugs Introduction
        11.8.4 Takeda Revenue in Oral Anti-diabetes Drugs Business (2017-2022)
        11.8.5 Takeda Recent Developments
    11.9 Bristol Myers Squibb
        11.9.1 Bristol Myers Squibb Company Details
        11.9.2 Bristol Myers Squibb Business Overview
        11.9.3 Bristol Myers Squibb Oral Anti-diabetes Drugs Introduction
        11.9.4 Bristol Myers Squibb Revenue in Oral Anti-diabetes Drugs Business (2017-2022)
        11.9.5 Bristol Myers Squibb Recent Developments
    11.10 Novartis
        11.10.1 Novartis Company Details
        11.10.2 Novartis Business Overview
        11.10.3 Novartis Oral Anti-diabetes Drugs Introduction
        11.10.4 Novartis Revenue in Oral Anti-diabetes Drugs Business (2017-2022)
        11.10.5 Novartis Recent Developments
    11.11 Pfizer
        11.11.1 Pfizer Company Details
        11.11.2 Pfizer Business Overview
        11.11.3 Pfizer Oral Anti-diabetes Drugs Introduction
        11.11.4 Pfizer Revenue in Oral Anti-diabetes Drugs Business (2017-2022)
        11.11.5 Pfizer Recent Developments
    11.12 Abbott
        11.12.1 Abbott Company Details
        11.12.2 Abbott Business Overview
        11.12.3 Abbott Oral Anti-diabetes Drugs Introduction
        11.12.4 Abbott Revenue in Oral Anti-diabetes Drugs Business (2017-2022)
        11.12.5 Abbott Recent Developments
    11.13 Biocon
        11.13.1 Biocon Company Details
        11.13.2 Biocon Business Overview
        11.13.3 Biocon Oral Anti-diabetes Drugs Introduction
        11.13.4 Biocon Revenue in Oral Anti-diabetes Drugs Business (2017-2022)
        11.13.5 Biocon Recent Developments
    11.14 Sunpharma
        11.14.1 Sunpharma Company Details
        11.14.2 Sunpharma Business Overview
        11.14.3 Sunpharma Oral Anti-diabetes Drugs Introduction
        11.14.4 Sunpharma Revenue in Oral Anti-diabetes Drugs Business (2017-2022)
        11.14.5 Sunpharma Recent Developments
    11.15 Novo Nordisk
        11.15.1 Novo Nordisk Company Details
        11.15.2 Novo Nordisk Business Overview
        11.15.3 Novo Nordisk Oral Anti-diabetes Drugs Introduction
        11.15.4 Novo Nordisk Revenue in Oral Anti-diabetes Drugs Business (2017-2022)
        11.15.5 Novo Nordisk Recent Developments
    11.16 Piramal Healthcare
        11.16.1 Piramal Healthcare Company Details
        11.16.2 Piramal Healthcare Business Overview
        11.16.3 Piramal Healthcare Oral Anti-diabetes Drugs Introduction
        11.16.4 Piramal Healthcare Revenue in Oral Anti-diabetes Drugs Business (2017-2022)
        11.16.5 Piramal Healthcare Recent Developments
    11.17 Bayer Healthcare
        11.17.1 Bayer Healthcare Company Details
        11.17.2 Bayer Healthcare Business Overview
        11.17.3 Bayer Healthcare Oral Anti-diabetes Drugs Introduction
        11.17.4 Bayer Healthcare Revenue in Oral Anti-diabetes Drugs Business (2017-2022)
        11.17.5 Bayer Healthcare Recent Developments
    11.18 Dr. Reddy’s Laboratories Ltd
        11.18.1 Dr. Reddy’s Laboratories Ltd Company Details
        11.18.2 Dr. Reddy’s Laboratories Ltd Business Overview
        11.18.3 Dr. Reddy’s Laboratories Ltd Oral Anti-diabetes Drugs Introduction
        11.18.4 Dr. Reddy’s Laboratories Ltd Revenue in Oral Anti-diabetes Drugs Business (2017-2022)
        11.18.5 Dr. Reddy’s Laboratories Ltd Recent Developments
    11.19 Glenmark Pharmaceuticals Ltd
        11.19.1 Glenmark Pharmaceuticals Ltd Company Details
        11.19.2 Glenmark Pharmaceuticals Ltd Business Overview
        11.19.3 Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Introduction
        11.19.4 Glenmark Pharmaceuticals Ltd Revenue in Oral Anti-diabetes Drugs Business (2017-2022)
        11.19.5 Glenmark Pharmaceuticals Ltd Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Oral Anti-diabetes Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Liquid
    Table 3. Key Players of Capsule
    Table 4. Key Players of Tablet
    Table 5. Global Oral Anti-diabetes Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Oral Anti-diabetes Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Oral Anti-diabetes Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Oral Anti-diabetes Drugs Market Share by Region (2017-2022)
    Table 9. Global Oral Anti-diabetes Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Oral Anti-diabetes Drugs Market Share by Region (2023-2028)
    Table 11. Oral Anti-diabetes Drugs Market Trends
    Table 12. Oral Anti-diabetes Drugs Market Drivers
    Table 13. Oral Anti-diabetes Drugs Market Challenges
    Table 14. Oral Anti-diabetes Drugs Market Restraints
    Table 15. Global Oral Anti-diabetes Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Oral Anti-diabetes Drugs Revenue Share by Players (2017-2022)
    Table 17. Global Top Oral Anti-diabetes Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Anti-diabetes Drugs as of 2021)
    Table 18. Ranking of Global Top Oral Anti-diabetes Drugs Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Oral Anti-diabetes Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Oral Anti-diabetes Drugs Product Solution and Service
    Table 22. Date of Enter into Oral Anti-diabetes Drugs Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Oral Anti-diabetes Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Oral Anti-diabetes Drugs Revenue Market Share by Type (2017-2022)
    Table 26. Global Oral Anti-diabetes Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Oral Anti-diabetes Drugs Revenue Market Share by Type (2023-2028)
    Table 28. Global Oral Anti-diabetes Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Oral Anti-diabetes Drugs Revenue Share by Application (2017-2022)
    Table 30. Global Oral Anti-diabetes Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Oral Anti-diabetes Drugs Revenue Share by Application (2023-2028)
    Table 32. North America Oral Anti-diabetes Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Oral Anti-diabetes Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Oral Anti-diabetes Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Oral Anti-diabetes Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Oral Anti-diabetes Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Oral Anti-diabetes Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Oral Anti-diabetes Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Oral Anti-diabetes Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Oral Anti-diabetes Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Oral Anti-diabetes Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Oral Anti-diabetes Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Oral Anti-diabetes Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Oral Anti-diabetes Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Oral Anti-diabetes Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Oral Anti-diabetes Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Oral Anti-diabetes Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Oral Anti-diabetes Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Oral Anti-diabetes Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Oral Anti-diabetes Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Oral Anti-diabetes Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Oral Anti-diabetes Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Oral Anti-diabetes Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Oral Anti-diabetes Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Oral Anti-diabetes Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Oral Anti-diabetes Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Oral Anti-diabetes Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Oral Anti-diabetes Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Oral Anti-diabetes Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Oral Anti-diabetes Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Oral Anti-diabetes Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Sanofi Company Details
    Table 63. Sanofi Business Overview
    Table 64. Sanofi Oral Anti-diabetes Drugs Product
    Table 65. Sanofi Revenue in Oral Anti-diabetes Drugs Business (2017-2022) & (US$ Million)
    Table 66. Sanofi Recent Developments
    Table 67. Eli Lilly Company Details
    Table 68. Eli Lilly Business Overview
    Table 69. Eli Lilly Oral Anti-diabetes Drugs Product
    Table 70. Eli Lilly Revenue in Oral Anti-diabetes Drugs Business (2017-2022) & (US$ Million)
    Table 71. Eli Lilly Recent Developments
    Table 72. AstraZeneca plc Company Details
    Table 73. AstraZeneca plc Business Overview
    Table 74. AstraZeneca plc Oral Anti-diabetes Drugs Product
    Table 75. AstraZeneca plc Revenue in Oral Anti-diabetes Drugs Business (2017-2022) & (US$ Million)
    Table 76. AstraZeneca plc Recent Developments
    Table 77. Astellas Pharma Inc Company Details
    Table 78. Astellas Pharma Inc Business Overview
    Table 79. Astellas Pharma Inc Oral Anti-diabetes Drugs Product
    Table 80. Astellas Pharma Inc Revenue in Oral Anti-diabetes Drugs Business (2017-2022) & (US$ Million)
    Table 81. Astellas Pharma Inc Recent Developments
    Table 82. Johnson & Johnson (Janssen Pharmaceuticals) Company Details
    Table 83. Johnson & Johnson (Janssen Pharmaceuticals) Business Overview
    Table 84. Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Product
    Table 85. Johnson & Johnson (Janssen Pharmaceuticals) Revenue in Oral Anti-diabetes Drugs Business (2017-2022) & (US$ Million)
    Table 86. Johnson & Johnson (Janssen Pharmaceuticals) Recent Developments
    Table 87. Boehringer Ingelheim Company Details
    Table 88. Boehringer Ingelheim Business Overview
    Table 89. Boehringer Ingelheim Oral Anti-diabetes Drugs Product
    Table 90. Boehringer Ingelheim Revenue in Oral Anti-diabetes Drugs Business (2017-2022) & (US$ Million)
    Table 91. Boehringer Ingelheim Recent Developments
    Table 92. Merck Company Details
    Table 93. Merck Business Overview
    Table 94. Merck Oral Anti-diabetes Drugs Product
    Table 95. Merck Revenue in Oral Anti-diabetes Drugs Business (2017-2022) & (US$ Million)
    Table 96. Merck Recent Developments
    Table 97. Takeda Company Details
    Table 98. Takeda Business Overview
    Table 99. Takeda Oral Anti-diabetes Drugs Product
    Table 100. Takeda Revenue in Oral Anti-diabetes Drugs Business (2017-2022) & (US$ Million)
    Table 101. Takeda Recent Developments
    Table 102. Bristol Myers Squibb Company Details
    Table 103. Bristol Myers Squibb Business Overview
    Table 104. Bristol Myers Squibb Oral Anti-diabetes Drugs Product
    Table 105. Bristol Myers Squibb Revenue in Oral Anti-diabetes Drugs Business (2017-2022) & (US$ Million)
    Table 106. Bristol Myers Squibb Recent Developments
    Table 107. Novartis Company Details
    Table 108. Novartis Business Overview
    Table 109. Novartis Oral Anti-diabetes Drugs Product
    Table 110. Novartis Revenue in Oral Anti-diabetes Drugs Business (2017-2022) & (US$ Million)
    Table 111. Novartis Recent Developments
    Table 112. Pfizer Company Details
    Table 113. Pfizer Business Overview
    Table 114. Pfizer Oral Anti-diabetes Drugs Product
    Table 115. Pfizer Revenue in Oral Anti-diabetes Drugs Business (2017-2022) & (US$ Million)
    Table 116. Pfizer Recent Developments
    Table 117. Abbott Company Details
    Table 118. Abbott Business Overview
    Table 119. Abbott Oral Anti-diabetes Drugs Product
    Table 120. Abbott Revenue in Oral Anti-diabetes Drugs Business (2017-2022) & (US$ Million)
    Table 121. Abbott Recent Developments
    Table 122. Biocon Company Details
    Table 123. Biocon Business Overview
    Table 124. Biocon Oral Anti-diabetes Drugs Product
    Table 125. Biocon Revenue in Oral Anti-diabetes Drugs Business (2017-2022) & (US$ Million)
    Table 126. Biocon Recent Developments
    Table 127. Sunpharma Company Details
    Table 128. Sunpharma Business Overview
    Table 129. Sunpharma Oral Anti-diabetes Drugs Product
    Table 130. Sunpharma Revenue in Oral Anti-diabetes Drugs Business (2017-2022) & (US$ Million)
    Table 131. Sunpharma Recent Developments
    Table 132. Novo Nordisk Company Details
    Table 133. Novo Nordisk Business Overview
    Table 134. Novo Nordisk Oral Anti-diabetes Drugs Product
    Table 135. Novo Nordisk Revenue in Oral Anti-diabetes Drugs Business (2017-2022) & (US$ Million)
    Table 136. Novo Nordisk Recent Developments
    Table 137. Piramal Healthcare Company Details
    Table 138. Piramal Healthcare Business Overview
    Table 139. Piramal Healthcare Oral Anti-diabetes Drugs Product
    Table 140. Piramal Healthcare Revenue in Oral Anti-diabetes Drugs Business (2017-2022) & (US$ Million)
    Table 141. Piramal Healthcare Recent Developments
    Table 142. Bayer Healthcare Company Details
    Table 143. Bayer Healthcare Business Overview
    Table 144. Bayer Healthcare Oral Anti-diabetes Drugs Product
    Table 145. Bayer Healthcare Revenue in Oral Anti-diabetes Drugs Business (2017-2022) & (US$ Million)
    Table 146. Bayer Healthcare Recent Developments
    Table 147. Dr. Reddy’s Laboratories Ltd Company Details
    Table 148. Dr. Reddy’s Laboratories Ltd Business Overview
    Table 149. Dr. Reddy’s Laboratories Ltd Oral Anti-diabetes Drugs Product
    Table 150. Dr. Reddy’s Laboratories Ltd Revenue in Oral Anti-diabetes Drugs Business (2017-2022) & (US$ Million)
    Table 151. Dr. Reddy’s Laboratories Ltd Recent Developments
    Table 152. Glenmark Pharmaceuticals Ltd Company Details
    Table 153. Glenmark Pharmaceuticals Ltd Business Overview
    Table 154. Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Product
    Table 155. Glenmark Pharmaceuticals Ltd Revenue in Oral Anti-diabetes Drugs Business (2017-2022) & (US$ Million)
    Table 156. Glenmark Pharmaceuticals Ltd Recent Developments
    Table 157. Research Programs/Design for This Report
    Table 158. Key Data Information from Secondary Sources
    Table 159. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Oral Anti-diabetes Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Liquid Features
    Figure 3. Capsule Features
    Figure 4. Tablet Features
    Figure 5. Global Oral Anti-diabetes Drugs Market Share by Application: 2021 VS 2028
    Figure 6. Hospital Pharmacies Case Studies
    Figure 7. Retail Pharmacies Case Studies
    Figure 8. Online Pharmacies Case Studies
    Figure 9. Oral Anti-diabetes Drugs Report Years Considered
    Figure 10. Global Oral Anti-diabetes Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Oral Anti-diabetes Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Oral Anti-diabetes Drugs Market Share by Region: 2021 VS 2028
    Figure 13. Global Oral Anti-diabetes Drugs Market Share by Players in 2021
    Figure 14. Global Top Oral Anti-diabetes Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Anti-diabetes Drugs as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Oral Anti-diabetes Drugs Revenue in 2021
    Figure 16. North America Oral Anti-diabetes Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Oral Anti-diabetes Drugs Market Size Market Share by Type (2017-2028)
    Figure 18. North America Oral Anti-diabetes Drugs Market Size Market Share by Application (2017-2028)
    Figure 19. North America Oral Anti-diabetes Drugs Market Size Share by Country (2017-2028)
    Figure 20. United States Oral Anti-diabetes Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Oral Anti-diabetes Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Oral Anti-diabetes Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Oral Anti-diabetes Drugs Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Oral Anti-diabetes Drugs Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Oral Anti-diabetes Drugs Market Size Share by Country (2017-2028)
    Figure 26. Germany Oral Anti-diabetes Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Oral Anti-diabetes Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Oral Anti-diabetes Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Oral Anti-diabetes Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Oral Anti-diabetes Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Oral Anti-diabetes Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Oral Anti-diabetes Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Oral Anti-diabetes Drugs Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Oral Anti-diabetes Drugs Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Oral Anti-diabetes Drugs Market Size Share by Region (2017-2028)
    Figure 36. China Oral Anti-diabetes Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Oral Anti-diabetes Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Oral Anti-diabetes Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Oral Anti-diabetes Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Oral Anti-diabetes Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Oral Anti-diabetes Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 42. Latin America Oral Anti-diabetes Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Oral Anti-diabetes Drugs Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Oral Anti-diabetes Drugs Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Oral Anti-diabetes Drugs Market Size Share by Country (2017-2028)
    Figure 46. Mexico Oral Anti-diabetes Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Oral Anti-diabetes Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Oral Anti-diabetes Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Oral Anti-diabetes Drugs Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Oral Anti-diabetes Drugs Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Oral Anti-diabetes Drugs Market Size Share by Country (2017-2028)
    Figure 52. Turkey Oral Anti-diabetes Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Oral Anti-diabetes Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Oral Anti-diabetes Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Sanofi Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2017-2022)
    Figure 56. Eli Lilly Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2017-2022)
    Figure 57. AstraZeneca plc Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2017-2022)
    Figure 58. Astellas Pharma Inc Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2017-2022)
    Figure 59. Johnson & Johnson (Janssen Pharmaceuticals) Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2017-2022)
    Figure 60. Boehringer Ingelheim Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2017-2022)
    Figure 61. Merck Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2017-2022)
    Figure 62. Takeda Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2017-2022)
    Figure 63. Bristol Myers Squibb Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2017-2022)
    Figure 64. Novartis Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2017-2022)
    Figure 65. Pfizer Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2017-2022)
    Figure 66. Abbott Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2017-2022)
    Figure 67. Biocon Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2017-2022)
    Figure 68. Sunpharma Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2017-2022)
    Figure 69. Novo Nordisk Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2017-2022)
    Figure 70. Piramal Healthcare Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2017-2022)
    Figure 71. Bayer Healthcare Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2017-2022)
    Figure 72. Dr. Reddy’s Laboratories Ltd Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2017-2022)
    Figure 73. Glenmark Pharmaceuticals Ltd Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2017-2022)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi
Eli Lilly
AstraZeneca plc
Astellas Pharma Inc
Johnson & Johnson (Janssen Pharmaceuticals)
Boehringer Ingelheim
Merck
Takeda
Bristol Myers Squibb
Novartis
Pfizer
Abbott
Biocon
Sunpharma
Novo Nordisk
Piramal Healthcare
Bayer Healthcare
Dr. Reddy’s Laboratories Ltd
Glenmark Pharmaceuticals Ltd
Frequently Asked Questions
Oral Anti-diabetes Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Oral Anti-diabetes Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Oral Anti-diabetes Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Stye Drugs

Stye Drugs market is segmented by players, region (country), by Type and by Application. Players, ... Read More